About 10 percent of neoplastic polyps incompletely resected

About 10 percent of neoplastic polyps incompletely resected
About 10 percent of neoplastic polyps are incompletely resected, with considerable variation in the rate of incomplete resection between endoscopists, according to a study published in the January issue of Gastroenterology.

(HealthDay)—About 10 percent of neoplastic polyps are incompletely resected, with considerable variation in the rate of incomplete resection between endoscopists, according to a study published in the January issue of Gastroenterology.

Heiko Pohl, M.D., from the VA Medical Center in White River Junction, Vermont, and colleagues obtained biopsies from resection margins of patients with at least one non-pedunculated polyp (5 to 20 mm) detected and removed during colonoscopy. The incomplete resection rate (IRR) was determined by the presence of neoplastic tissue in post-polypectomy biopsies.

The researchers found that 10.1 percent of the 346 neoplastic polyps (269 patients; 84.0 percent men; mean age, 63.4 years) removed by 11 were incompletely resected. The IRR was significantly higher for large (10 to 20 mm) versus small (5 to 9 mm) neoplastic polyps (17.3 versus 6.8 percent; relative risk, 2.1), and also for sessile serrated adenomas/polyps versus conventional (31.0 versus 7.2 percent; relative risk, 3.7). The IRR ranged from 6.5 to 22.7 percent for endoscopists with at least 20 polypectomies. After adjustment for size and sessile serrated histology, there was a 3.4-fold difference between the highest and lowest IRR for endoscopists.

"Our results suggest a need for quality metrics evaluating polyp resection," the authors write. "The performance of high-quality and effective not only requires expertise in finding neoplastic polyps, but also removing them."

More information: Abstract
Full Text
Editorial

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Ebola vaccine promising in first human trials

1 hour ago

Researchers say they are one step closer to developing a viable Ebola vaccine, with a Phase 1 trial showing promising results, but it will still be months at least before it could be used in the field.

At one month, US Ebola monitors finding no cases

4 hours ago

The U.S. program that requires weeks of monitoring for travelers from African countries with Ebola reaches the one-month mark Thursday. And so far, no cases of the disease have turned up.

EU calls for 5,000 doctors to fight Ebola

4 hours ago

The European Commission called for 5,000 doctors to be sent from EU states to combat west Africa's Ebola epidemic, a European source with knowledge of the matter said on Wednesday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.